HCTI amends acquisition terms to give seller 1.388M shares after reverse split; discloses audited financials

Healthcare Triangle, Inc.

Amendment replaces stock consideration with 1,388,041 restricted shares, reflecting 1-for-249 reverse split, subject to shareholder approval.
Niyama audited FY2024: revenue $3K, net loss $37K; Ezovion: revenue $258K, net income $13K.
Pro forma combined FY2024 revenue $11.96M, net loss $5.99M; HCTI standalone had $1.1M AR and $2.65M short-term borrowing.
HCTI standalone total liabilities $9.78M vs total assets $7.66M; combined assets $8.24M.
Acquired entities contribute minimal revenue/assets relative to HCTI's existing losses; deal still requires shareholder approval.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.